Evidence map›Paper›PMID 29678786›Full record

ArticleToxicology in vitro : an international journal published in association with BIBRA2018

Fetal bovine serum induces sustained, but reversible, epithelial-mesenchymal transition in the BEAS-2B cell line.

S W Malm, E A Amouzougan, W T Klimecki

Abstract read
In one paragraph

Article in Toxicology in vitro : an international journal published in association with BIBRA, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Advancing Environmental ToxicologyEnvironment & health (Washington, D.C.) · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. miRNAs and arsenic-induced carcinogenesis.Advances in pharmacology (San Diego, Calif.) · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S W MalmDepartment of Pharmacology and Toxicology, University of Arizona, 1703 E. Mabel St. Room 344, Tucson, AZ 85721, USA. Electronic address: malm@pharmacy.arizona.edu.
E A AmouzouganDepartment of Pharmacology and Toxicology, University of Arizona, 1703 E. Mabel St. Room 344, Tucson, AZ 85721, USA. Electronic address: amouzougan@pharmacy.arizona.edu.
W T KlimeckiDepartment of Pharmacology and Toxicology, University of Arizona, 1703 E. Mabel St. Room 344, Tucson, AZ 85721, USA. Electronic address: klimecki@pharmacy.arizona.edu.

Funding

SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Training in Environmental Toxicology of Human DiseaseT32ES007091 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1985 to 2026
$10.7M
Arsenic carcinogenicity: Metabolic disruption leads to loss of PTEN functionR03ES023921 · NIEHS · UNIVERSITY OF ARIZONA · PI KLIMECKI, WALTER T · 2014 to 2015
$152k
NIEHS NIH HHS P30 ES006694NIEHS NIH HHS R03 ES023921NIEHS NIH HHS T32 ES007091
6 · The paper itself

Abstract

BEAS-2B is a non-malignant, immortalized human cell line that has been used extensively as a model of lung epithelium. Despite ATCC recommendations to culture BEAS-2B in defined, serum-free media, many publications describe culturing BEAS-2B in fetal bovine serum (FBS)-containing media. The objective of this study was to define the effects of FBS on BEAS-2B cells. FBS exposure resulted in increased nuclear levels of transcription factors responsible for regulating epithelial-mesenchymal transition (EMT), increased cell invasiveness and increased anchorage-independent growth. FBS-exposed BEAS-2B cells exhibited a decrease of the epithelial markers, E-cadherin and claudin-1 at the mRNA and protein levels, along with a corresponding increase of the mesenchymal marker, vimentin, at the protein level. Fractionation studies implicated an active moiety in FBS with a molecular weight larger than 30 kD. The mesenchymal phenotype was persistent provided FBS exposure was maintained. Upon FBS removal, both epithelial and mesenchymal markers began to revert toward an epithelial phenotype. Transforming growth factor β1 (TGFβ1) exposure to BEAS-2B recapitulated some key features of FBS-induced EMT. Our data suggest that FBS-exposed BEAS-2B cells do not accurately model the epithelial phenotype. Interpretation of data from BEAS-2B should include careful consideration of the effect of culture conditions.

Indexed as

SerumAnimalsAntigens, CDCadherinsCattleCell LineClaudin-1Epithelial-Mesenchymal TransitionHumansPhenotypeTransforming Growth Factor beta1VimentinAntigens, CDCadherinsCDH1 protein, humanClaudin-1CLDN1 protein, humanTransforming Growth Factor beta1VimentinBEAS-2BCell cultureEpithelialEpithelial-mesenchymal transitionRespiratoryTGF

Identifiers

PMID29678786
PMCPMC6084805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.